Drug Type Small molecule drug |
Synonyms GNE 6468, GNE6468 |
Target |
Mechanism RORG inverse agonists(Nuclear receptor ROR-gamma inverse agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H16ClN3O4 |
InChIKeyGIYKJPISDNWSJD-UHFFFAOYSA-N |
CAS Registry1677668-27-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 01 Aug 2015 | |
Autoimmune Diseases | Preclinical | CN | 01 Aug 2015 |